Combination of Fedratinib and Decitabine for Myeloproliferative Neoplasms (MPN)- Accelerated Phase (AP)/Blast Phase (BP)

Clinical trial NCT05524857 · TERMINATED

Trial details

NCT number: NCT05524857
Sponsor: Joseph Jurcic
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Myeloproliferative Neoplasm

Start date: 2022-01-28
Primary completion: 2024-04-09
Enrollment: 2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.